Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
2.
Oncotarget ; 8(24): 38239-38250, 2017 Jun 13.
Artículo en Inglés | MEDLINE | ID: mdl-28415677

RESUMEN

In gene therapy, effective and selective suicide gene expression is crucial. We exploited the endogenous Long INterspersed Element-1 (L1) machinery often reactivated in human cancers to integrate the Herpes Simplex Virus Thymidine Kinase (HSV-TK) suicide gene selectively into the genome of cancer cells. We developed a plasmid-based system directing HSV-TK expression only when reverse transcribed and integrated in the host genome via the endogenous L1 ORF1/2 proteins and an Alu element. Delivery of these new constructs into cells followed by Ganciclovir (GCV) treatment selectively induced mortality of L1 ORF1/2 protein expressing cancer cells, but had no effect on primary cells that do not express L1 ORF1/2. This novel strategy for selective targeting of tumour cells provides high tolerability as the HSV-TK gene cannot be expressed without reverse transcription and integration, and high selectivity as these processes take place only in cancer cells expressing high levels of functional L1 ORF1/2.


Asunto(s)
Genes Transgénicos Suicidas , Terapia Genética/métodos , Elementos de Nucleótido Esparcido Largo , Línea Celular Tumoral , Endonucleasas/metabolismo , Ganciclovir/farmacología , Técnicas de Transferencia de Gen , Vectores Genéticos/genética , Humanos , Proteínas/metabolismo , ADN Polimerasa Dirigida por ARN/metabolismo , Simplexvirus/genética , Timidina Quinasa/genética
3.
Curr Top Dev Biol ; 104: 1-45, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-23587237

RESUMEN

Early embryonic development in mammals is characterized by major changes in the components of the chromatin and its remodeling. The embryonic chromatin and the nuclear organization in the mouse preimplantation embryo display particular features that are dramatically different from somatic cells. These include the highly specific organization of the pericentromeric heterochromatin within the nucleus and the suggested lack of conventional heterochromatin. We postulate that the plasticity of the cells in the early embryo relies on the distinctive heterochromatin features that prevail during early embryogenesis. Here, we review some of these features and discuss recent findings on the mechanisms driving heterochromatin formation after fertilization, in particular, the emerging role of RNA as a regulator of heterochromatic loci also in mammals. Finally, we believe that there are at least three major avenues that should be addressed in the coming years: (i) Is heterochromatin a driving force in development? (ii) Does it have a role in lineage allocation? (iii) How can heterochromatin "regulate" epigenetic reprogramming?


Asunto(s)
Heterocromatina/metabolismo , Mamíferos/crecimiento & desarrollo , Mamíferos/genética , Animales , Metilación de ADN/genética , Embrión de Mamíferos/metabolismo , Histonas/metabolismo , Humanos , Patrón de Herencia/genética
4.
Nat Struct Mol Biol ; 20(3): 332-8, 2013 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-23353788

RESUMEN

How a more plastic chromatin state is maintained and reversed during development is unknown. Heterochromatin-mediated silencing of repetitive elements occurs in differentiated cells. Here, we used repetitive elements, including retrotransposons, as model loci to address how and when heterochromatin forms during development. RNA sequencing throughout early mouse embryogenesis revealed that repetitive-element expression is dynamic and stage specific, with most repetitive elements becoming repressed before implantation. We show that LINE-1 and IAP retrotransposons become reactivated from both parental genomes after fertilization. Chromatin immunoprecipitation for H3K4me3 and H3K9me3 in 2- and 8-cell embryos indicates that their developmental silencing follows loss of activating marks rather than acquisition of conventional heterochromatic marks. Furthermore, short LINE-1 RNAs regulate LINE-1 transcription in vivo. Our data indicate that reprogramming after mammalian fertilization comprises a robust transcriptional activation of retrotransposons and that repetitive elements are initially regulated through RNA.


Asunto(s)
Blastocisto/fisiología , Metilación de ADN , Regulación del Desarrollo de la Expresión Génica , Heterocromatina/genética , Elementos de Nucleótido Esparcido Largo , Animales , Inmunoprecipitación de Cromatina , Desarrollo Embrionario/genética , Femenino , Histonas/genética , Histonas/metabolismo , Masculino , Ratones , Ratones Endogámicos C57BL , Conformación de Ácido Nucleico , Caperuzas de ARN , Retroelementos , Transcripción Genética
5.
Development ; 134(16): 2947-58, 2007 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-17626060

RESUMEN

The TAF4 subunit of transcription factor TFIID was inactivated in the basal keratinocytes of foetal and adult mouse epidermis. Loss of TAF4 in the foetal epidermis results in reduced expression of the genes required for skin barrier function, leading to early neonatal death. By contrast, TAF4 inactivation in adult epidermis leads to extensive fur loss and an aberrant hair cycle characterised by a defective anagen phase. Although the mutant epidermis contains few normal anagen-phase hair follicles, many genes expressed at this stage are strongly upregulated indicating desynchronized and inappropriate gene expression. The TAF4 mutant adult epidermis also displays interfollicular hyperplasia associated with a potent upregulation of several members of the EGF family of mitogens. Moreover, loss of TAF4 leads to malignant transformation of chemically induced papillomas and the appearance of invasive melanocytic tumours. Together, our results show that TAF4 is an important regulator of keratinocyte proliferation and has cell-autonomous and non-cell-autonomous tumour suppressor activity.


Asunto(s)
Proliferación Celular , Epidermis/metabolismo , Queratinocitos/citología , Factores Asociados con la Proteína de Unión a TATA/metabolismo , Factores Asociados con la Proteína de Unión a TATA/fisiología , Factor de Transcripción TFIID/metabolismo , Factor de Transcripción TFIID/fisiología , Proteínas Supresoras de Tumor/metabolismo , Animales , Diferenciación Celular/genética , Epidermis/embriología , Epidermis/patología , Femenino , Predisposición Genética a la Enfermedad , Cabello/citología , Cabello/embriología , Hiperplasia/inducido químicamente , Masculino , Ratones , Ratones Noqueados , Nevo Pigmentado/inducido químicamente , Nevo Pigmentado/genética , Subunidades de Proteína/fisiología , Neoplasias Cutáneas/inducido químicamente , Neoplasias Cutáneas/patología , Factores Asociados con la Proteína de Unión a TATA/genética , Factor de Transcripción TFIID/genética , Tretinoina/efectos adversos , Proteínas Supresoras de Tumor/fisiología
6.
Cell Cycle ; 4(11): 1486-90, 2005 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-16205117

RESUMEN

RNA polymerase II general transcription factor TFIID is a macromolecular complex comprising the TATA-binding protein, TBP and 13-14 evolutionary conserved TBP-associated factors, TAFs. Although genetic experiments have shown that TAFs are essential for cell cycle progression in yeast and in rapidly proliferating vertebrate cells in vitro, new experiments indicate they may be dispensible in specific developmental and physiological processes. Moreover, the TAF4 subunit of TFIID negatively regulates proliferation by inhibiting activation of the TGFbeta signalling pathway by its paralogue TAF4b. TAF4 is however essential in the retinoic acid and cAMP signalling pathways acting as a cofactor for CREB and the retinoic acid receptor, but is a negative regulator of the ATF7 transcription factor.


Asunto(s)
Ciclo Celular/fisiología , Transducción de Señal/fisiología , Factores Asociados con la Proteína de Unión a TATA/fisiología , Animales , Ciclo Celular/genética , Humanos , Transducción de Señal/genética
7.
EMBO J ; 24(15): 2753-67, 2005 Aug 03.
Artículo en Inglés | MEDLINE | ID: mdl-16015375

RESUMEN

We have inactivated transcription factor TFIID subunit TBP-associated factor 4 (TAF4) in mouse embryonic fibroblasts. Mutant taf4(-/-) cells are viable and contain intact TFIID comprising the related TAF4b showing that TAF4 is not an essential protein. TAF4 inactivation deregulates more than 1000 genes indicating that TFIID complexes containing TAF4 and TAF4b have distinct target gene specificities. However, taf4(-/-) cell lines have altered morphology and exhibit serum-independent autocrine growth correlated with the induced expression of several secreted mitotic factors and activators of the transforming growth factor beta signalling pathway. In addition to TAF4 inactivation, many of these genes can also be induced by overexpression of TAF4b. A competitive equilibrium between TAF4 and TAF4b therefore regulates expression of genes controlling cell proliferation. We have further identified a set of genes that are regulated both by TAF4 and upon adaptation to serum starvation and which may be important downstream mediators of serum-independent growth. Our study also shows that TAF4 is an essential cofactor for activation by the retinoic acid receptor and CREB, but not for Sp1 and the vitamin D3 receptor.


Asunto(s)
Comunicación Autocrina/fisiología , Fibroblastos/metabolismo , Transducción de Señal/fisiología , Factores Asociados con la Proteína de Unión a TATA/antagonistas & inhibidores , Factores Asociados con la Proteína de Unión a TATA/metabolismo , Factor de Transcripción TFIID/antagonistas & inhibidores , Factor de Transcripción TFIID/metabolismo , Factor de Crecimiento Transformador beta/metabolismo , Animales , Supervivencia Celular/fisiología , Proteína de Unión a Elemento de Respuesta al AMP Cíclico/metabolismo , Regulación de la Expresión Génica , Immunoblotting , Ratones , Estructura Terciaria de Proteína , Receptores de Ácido Retinoico/metabolismo , Factores Asociados con la Proteína de Unión a TATA/genética , Factor de Transcripción TFIID/genética
8.
Biochem Pharmacol ; 69(8): 1167-76, 2005 Apr 15.
Artículo en Inglés | MEDLINE | ID: mdl-15794937

RESUMEN

Photodynamic therapy (PDT) is an approved anticancer treatment modality that eliminates unwanted cells by the photochemical generation of reactive oxygen species following absorption of visible light by a photosensitizer, which is selectively taken up by tumor cells. Present study reports the modalities of cell death after photosensitization of human adenocarcinoma HT29 monolayer and spheroid cells with a second generation photosensitizer Foscan. Kinetics of apoptosis and necrosis after Foscan-PDT in monolayer cells determined by flow cytometry using labeling of cleaved poly(ADP-ribose) polymerase (PARP) and staining with propidium iodide (PI) demonstrated that Foscan was not a strong inducer of apoptosis and necrosis was a prevailing mode of cell death. Cytochrome c release (cyt c) and mitochondrial membrane potential (Deltapsim) addressed by flow cytometry technique at different time points post-Foscan-PDT demonstrated that cell photoinactivation was governed by these mitochondrial events. Foscan-loaded HT29 multicell spheroids, subjected to irradiation with different fluence rates and equivalent light doses, displayed much better tumoricidal activity at the lowest fluence rate used. Apoptosis, measured by caspase-3 activation was evidenced only in spheroids irradiated with the lowest fluence rate and moderate fluence inducing 65% of cell death. Application of higher fluence rates for the same level of photocytotoxicity did not result in caspase-3 activation. The observation of the fluence rate-dependent modulation of caspase-3 activity in spheroids offers the possibility of regulating the mechanism of direct cell photodamage and could be of great potential in the clinical context.


Asunto(s)
Apoptosis/efectos de los fármacos , Neoplasias del Colon/tratamiento farmacológico , Neoplasias del Colon/patología , Mesoporfirinas/farmacología , Fármacos Fotosensibilizantes/farmacología , Esferoides Celulares/efectos de los fármacos , Western Blotting , Caspasa 3 , Caspasas/análisis , Caspasas/metabolismo , Muerte Celular/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Neoplasias del Colon/metabolismo , Citocromos c/metabolismo , Relación Dosis-Respuesta a Droga , Activación Enzimática , Citometría de Flujo , Células HT29 , Humanos , Cinética , Potenciales de la Membrana/efectos de los fármacos , Mitocondrias/efectos de los fármacos , Mitocondrias/fisiología , Necrosis/patología , Fotoquimioterapia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...